Stock A001540 AHN-GOOK PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ahn-Gook Pharmaceutical Co., Ltd.

Equities

A001540

KR7001540004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
7,520 KRW +0.67% Intraday chart for Ahn-Gook Pharmaceutical Co., Ltd. -0.27% -20.09%
16/05 Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
20/03 Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,13,958 1,23,186 1,48,969 1,22,613 1,04,448 1,06,948
Enterprise Value (EV) 1 79,288 72,802 1,19,504 95,344 86,011 89,181
P/E ratio 8.71 x 48.6 x -113 x 31.1 x 15.2 x 82.9 x
Yield 2.22% 2.05% 1.69% 2.06% 2.39% 2.34%
Capitalization / Revenue 0.61 x 0.79 x 1.04 x 0.75 x 0.51 x 0.46 x
EV / Revenue 0.43 x 0.47 x 0.83 x 0.58 x 0.42 x 0.38 x
EV / EBITDA 4.26 x 11.6 x 25.8 x 27.9 x 6.01 x 8.84 x
EV / FCF -15 x 4.16 x -9.75 x -96.5 x 49.7 x 19.9 x
FCF Yield -6.65% 24.1% -10.3% -1.04% 2.01% 5.04%
Price to Book 0.77 x 0.83 x 1.03 x 0.8 x 0.67 x 0.7 x
Nbr of stocks (in thousands) 11,511 11,459 11,459 11,459 11,365 11,365
Reference price 2 9,900 10,750 13,000 10,700 9,190 9,410
Announcement Date 21/03/19 12/03/20 17/03/21 21/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,85,746 1,55,852 1,43,364 1,63,534 2,05,389 2,33,676
EBITDA 1 18,629 6,272 4,634 3,423 14,311 10,084
EBIT 1 15,366 2,418 -49.1 -1,084 9,381 5,061
Operating Margin 8.27% 1.55% -0.03% -0.66% 4.57% 2.17%
Earnings before Tax (EBT) 1 16,366 2,176 778.1 3,805 7,375 4,267
Net income 1 13,220 2,536 -1,315 3,939 6,875 1,290
Net margin 7.12% 1.63% -0.92% 2.41% 3.35% 0.55%
EPS 2 1,136 221.3 -114.8 343.9 604.0 113.5
Free Cash Flow 1 -5,274 17,516 -12,257 -988.1 1,732 4,491
FCF margin -2.84% 11.24% -8.55% -0.6% 0.84% 1.92%
FCF Conversion (EBITDA) - 279.29% - - 12.1% 44.54%
FCF Conversion (Net income) - 690.79% - - 25.19% 348.14%
Dividend per Share 2 220.0 220.0 220.0 220.0 220.0 220.0
Announcement Date 21/03/19 12/03/20 17/03/21 21/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 34,670 50,384 29,465 27,269 18,437 17,767
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5,274 17,516 -12,257 -988 1,732 4,491
ROE (net income / shareholders' equity) 9.26% 1.45% -0.95% 2.52% 4.47% 0.65%
ROA (Net income/ Total Assets) 4.56% 0.7% -0.01% -0.32% 2.64% 1.37%
Assets 1 2,89,753 3,61,508 90,09,430 -12,26,025 2,60,264 94,314
Book Value Per Share 2 12,808 12,937 12,575 13,441 13,683 13,382
Cash Flow per Share 2 1,874 1,985 1,114 1,196 1,610 2,551
Capex 1 2,914 3,738 24,119 4,035 2,931 5,474
Capex / Sales 1.57% 2.4% 16.82% 2.47% 1.43% 2.34%
Announcement Date 21/03/19 12/03/20 17/03/21 21/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
AHN-GOOK PHARMACEUTICAL CO., LTD. Stock Ahn-Gook Pharmaceutical Co., Ltd.
-20.09% 6.18Cr
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+15.91% 4.2TCr
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+22.40% 2.23TCr
SANDOZ GROUP AG Stock Sandoz Group AG
+18.48% 1.52TCr
CIPLA LIMITED Stock Cipla Limited
+16.12% 1.4TCr
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+45.12% 1.21TCr
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.58% 679.6Cr
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 678.76Cr
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.18% 549.33Cr
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A001540 Stock
  4. Financials Ahn-Gook Pharmaceutical Co., Ltd.